The inhibition of POSTN and TBK1 in GBM mouse models, as well as pathological analysis in GBM patient samples, reveal that this pathway may be an interesting therapeutic strategy for targeting GBM angiogenesis (49). Here, POSTN is linked to glioblastoma.